285
Views
3
CrossRef citations to date
0
Altmetric
Original Articles: Research

Recurrent breakpoints in 14q32.13/TCL1A region in mature B-cell neoplasms with villous lymphocytes

, , , , , , , , , , , , , , , & show all
Pages 2449-2455 | Received 23 Feb 2012, Accepted 26 Apr 2012, Published online: 04 May 2012

References

  • Tiacci E, Liso A, Piris M, . Evolving concepts in the pathogenesis of hairy-cell leukaemia. Nat Rev Cancer 2006;6:437–448.
  • Matutes E, Wotherspoon A, Catovsky D. The variant form of hairy-cell leukaemia. Best Pract Res Clin Haematol 2003;16:41–56.
  • Matutes E, Morilla R, Owusuankomah K, . The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential-diagnosis with other B-cell disorders. Blood 1994;83:1558–1562.
  • Swerdlow SH, Campo E, Harris NL, . WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.
  • Hockley SL, Giannouli S, Morilla A, . Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns. Br J Haematol 2010;148:666–669.
  • Hockley SL, Morgan GJ, Leone PE, . High-resolution genomic profiling in hairy cell leukemia-variant compared with typical hairy cell leukemia. Leukemia 2011;25:1189–1192.
  • Algara P, Mateo MS, Sanchez-Beato M, . Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood 2002;99:1299–1304.
  • Arons E, Sunshine J, Suntum T, . Somatic hypermutation and VH gene usage in hairy cell leukaemia. Br J Haematol 2006;133:504–512.
  • Dearden C, Else M. Hairy cell leukemia. Curr Oncol Rep 2006;8: 337–342.
  • Matutes E. Splenic marginal zone lymphoma with and without villous lymphocytes. Curr Treat Options Oncol 2007;8:109–116.
  • Tierens A, Delabie J, Malecka A, . Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations. Am J Pathol 2003;162:681–689.
  • Vanhentenrijk V, Tierens A, Wlodarska I, . V-H gene analysis of hairy cell leukemia reveals a homogeneous mutation status and suggests its marginal zone B-cell origin. Leukemia 2004;18:1729–1732.
  • Arcaini L, Lazzarino M, Colombo N, . Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 2006;107: 4643–4649.
  • Else M, Ruchlemer R, Osuji N, . Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years. Cancer 2005;104:2442–2448.
  • Gidron A, Tallman MS. Hairy cell leukemia: towards a curative strategy. Hematol Oncol Clin North Am 2006;20:1153–1162.
  • Salido M, Baro C, Oscier D, . Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group. Blood 2010;116:1479–1488.
  • Arcaini L, Zibellini S, Boveri E, . The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood 2012;119:188–191.
  • Tiacci E, Trifonov V, Schiavoni G, . BRAF mutations in hairy-cell leukemia. N Engl J Med 2011;364:2305–2315.
  • Tiacci E, Schiavoni G, Forconi F, . Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood 2012;119:192–195.
  • Cawley JC, Burns GF, Hayhoe FG. A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia. Leuk Res 1980;4:547–559.
  • Robak T. Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment. Cancer Treat Rev 2011;37:3–10.
  • Falini B, Tiacci E, Liso A, . Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 2004;363:1869–1870. Erratum in Lancet 2004;363:2194.
  • Pospisilova H, Baens M, Michaux L, . Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL. Leukemia 2007;21:2079–2083.
  • Akasaka T, Balasas T, Russell LJ, . Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 2007;109:3451–3461.
  • Pekarsky Y, Hallas C, Isobe M, . Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. Proc Natl Acad Sci USA 1999;96:2949–2951.
  • Saitou M, Sugimoto J, Hatakeyama T, . Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia. Oncogene 2000;19:2796–2802.
  • Bichi R, Shinton SA, Martin ES, . Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 2002;99:6955–6960.
  • Nakayama I, Murao S, Kitazawa S, . Activation of the TCL1 protein in B cell lymphomas. Pathol Int 2000;50:191–199.
  • Ruiz-Ballesteros E, Mollejo M, Mateo M, . MicroRNA losses in the frequently deleted region of 7q in SMZL. Leukemia 2007;21: 2547–2549.
  • Iqbal J, Greiner TC, Patel K, . Leukemia/Lymphoma Molecular Profiling Project. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia 2007;11:2332–2343.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.